The Correction of Midface Volume Deficiency and/or Midface Contour Deficiency

Summary

The objective of this clinical trial is to evaluate the efficacy and safety of PEGDE-crosslinked hyaluronic acid hydrogels for the correction of midface volume deficiency and/or midface contour deficiency, on the premise of ensuring the safety of the subjects and maintaining the scientific integrity of the clinical trial.

Timeline

Start

2025-03-19

Primary completion

2026-11-01

Completion

2027-02-27

Drugs

Indications